Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F9R4Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,330
Award facts
- Contract value 100% obligated
- $22,330.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 27, 2026, the Defense Logistics Agency awarded a delivery order valued at $22,330.20 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, which has no set-aside designation, is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania, with ultimate completion scheduled for January 28, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems.
REPATHA is a prescription medication used to lower cholesterol and reduce cardiovascular risk in patients with certain conditions. This delivery order represents a routine task order draw against AmerisourceBergen's existing pharmaceutical supply agreement with DLA, which enables the contractor to supply a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally. The contract structure demonstrates the efficiency of the IDC vehicle in facilitating rapid procurement of essential pharmaceutical products for government healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F9R4Q?
SPE2DR26F9R4Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F9R4Q worth?
The government has obligated $22,330 on SPE2DR26F9R4Q.
Is contract SPE2DR26F9R4Q an order under another contract?
Yes. SPE2DR26F9R4Q is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9R4Q competed?
The extent of competition for SPE2DR26F9R4Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award